vs
Assertio Holdings, Inc.（ASRT）与WEST BANCORPORATION INC（WTBA）财务数据对比。点击上方公司名可切换其他公司
WEST BANCORPORATION INC的季度营收约是Assertio Holdings, Inc.的2.0倍（$26.9M vs $13.5M），WEST BANCORPORATION INC同比增速更快（16.6% vs -57.9%），过去两年WEST BANCORPORATION INC的营收复合增速更高（17.3% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
West Bancorporation Inc.是总部位于美国中西部的区域性金融控股公司，主要服务爱荷华州、明尼苏达州两地市场，面向不同群体提供多元化个人及商业银行服务，包括存款账户、按揭贷款、企业信贷、财富管理等专业解决方案，覆盖个人客户、中小企业及本地机构客户。
ASRT vs WTBA — 直观对比
营收规模更大
WTBA
是对方的2.0倍
$13.5M
营收增速更快
WTBA
高出74.5%
-57.9%
两年增速更快
WTBA
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $26.9M |
| 净利润 | — | $10.6M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 50.0% |
| 净利率 | — | 39.2% |
| 营收同比 | -57.9% | 16.6% |
| 净利润同比 | — | 34.8% |
| 每股收益（稀释后） | $-4.54 | $0.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTWTBA
| Q1 26 | — | $26.9M | ||
| Q4 25 | $13.5M | $24.2M | ||
| Q3 25 | $49.5M | $25.0M | ||
| Q2 25 | $29.2M | $23.8M | ||
| Q1 25 | $26.5M | $23.1M | ||
| Q4 24 | $32.2M | $20.9M | ||
| Q3 24 | $29.2M | $20.3M | ||
| Q2 24 | $31.1M | $19.6M |
净利润ASRTWTBA
| Q1 26 | — | $10.6M | ||
| Q4 25 | — | $7.4M | ||
| Q3 25 | $11.4M | $9.3M | ||
| Q2 25 | $-16.4M | $8.0M | ||
| Q1 25 | $-13.5M | $7.8M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | $-2.9M | $6.0M | ||
| Q2 24 | $-3.7M | $5.2M |
营业利润率ASRTWTBA
| Q1 26 | — | 50.0% | ||
| Q4 25 | -86.7% | 39.6% | ||
| Q3 25 | 23.2% | 45.8% | ||
| Q2 25 | -27.5% | 43.4% | ||
| Q1 25 | -50.0% | 43.4% | ||
| Q4 24 | -41.9% | 30.9% | ||
| Q3 24 | -10.4% | 36.6% | ||
| Q2 24 | -11.6% | 32.6% |
净利率ASRTWTBA
| Q1 26 | — | 39.2% | ||
| Q4 25 | — | 30.7% | ||
| Q3 25 | 23.1% | 37.3% | ||
| Q2 25 | -56.0% | 33.5% | ||
| Q1 25 | -51.1% | 34.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | -10.0% | 29.3% | ||
| Q2 24 | -11.8% | 26.5% |
每股收益（稀释后）ASRTWTBA
| Q1 26 | — | $0.61 | ||
| Q4 25 | $-4.54 | $0.44 | ||
| Q3 25 | $0.11 | $0.55 | ||
| Q2 25 | $-0.17 | $0.47 | ||
| Q1 25 | $-0.14 | $0.46 | ||
| Q4 24 | $-3.28 | $0.41 | ||
| Q3 24 | $-0.03 | $0.35 | ||
| Q2 24 | $-0.04 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $362.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $270.7M |
| 总资产 | $267.0M | $4.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTWTBA
| Q1 26 | — | $362.0M | ||
| Q4 25 | $63.4M | $471.1M | ||
| Q3 25 | $93.4M | $232.9M | ||
| Q2 25 | $98.2M | $345.2M | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | $243.5M | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — |
股东权益ASRTWTBA
| Q1 26 | — | $270.7M | ||
| Q4 25 | $94.0M | $266.0M | ||
| Q3 25 | $105.8M | $255.1M | ||
| Q2 25 | $93.3M | $240.9M | ||
| Q1 25 | $108.5M | $237.9M | ||
| Q4 24 | $121.1M | $227.9M | ||
| Q3 24 | $130.5M | $235.4M | ||
| Q2 24 | $132.2M | $223.9M |
总资产ASRTWTBA
| Q1 26 | — | $4.0B | ||
| Q4 25 | $267.0M | $4.1B | ||
| Q3 25 | $319.8M | $4.0B | ||
| Q2 25 | $273.8M | $4.1B | ||
| Q1 25 | $286.4M | $4.0B | ||
| Q4 24 | $284.7M | $4.0B | ||
| Q3 24 | $276.0M | $4.0B | ||
| Q2 24 | $279.4M | $4.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $12.9M |
| 自由现金流经营现金流 - 资本支出 | — | $12.4M |
| 自由现金流率自由现金流/营收 | — | 46.0% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | — | 1.22× |
| 过去12个月自由现金流最近4个季度 | — | $79.1M |
8季度趋势，按日历期对齐
经营现金流ASRTWTBA
| Q1 26 | — | $12.9M | ||
| Q4 25 | $-30.0M | $46.5M | ||
| Q3 25 | $-4.8M | $11.4M | ||
| Q2 25 | $19.1M | $13.5M | ||
| Q1 25 | $-12.5M | $9.7M | ||
| Q4 24 | $11.5M | $39.8M | ||
| Q3 24 | $-35.0K | $12.9M | ||
| Q2 24 | $7.4M | $10.0M |
自由现金流ASRTWTBA
| Q1 26 | — | $12.4M | ||
| Q4 25 | — | $43.2M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $12.8M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | — | $13.7M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $2.7M |
自由现金流率ASRTWTBA
| Q1 26 | — | 46.0% | ||
| Q4 25 | — | 178.3% | ||
| Q3 25 | — | 43.0% | ||
| Q2 25 | — | 53.6% | ||
| Q1 25 | — | 35.7% | ||
| Q4 24 | — | 65.6% | ||
| Q3 24 | — | 34.2% | ||
| Q2 24 | — | 14.0% |
资本支出强度ASRTWTBA
| Q1 26 | — | 1.8% | ||
| Q4 25 | — | 13.7% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | 125.3% | ||
| Q3 24 | 0.0% | 29.4% | ||
| Q2 24 | — | 37.1% |
现金转化率ASRTWTBA
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | -0.42× | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 1.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
WTBA
暂无分部数据
